Skip to content

Science1 publisherNot yet confirmed elsewhere2 min readPublished

UCL preprint maps 2-micrometre channels that carried tau and amyloid toward the mouse brain surface

UCL researchers report a mesh of 2-micrometre channels that carried labelled tau and amyloid beta toward the brain surface in mice, in an unreviewed preprint. They are a candidate exit for the proteins that build up in Alzheimer's, so far untested in a living human brain.

The Scientist · Science desk

Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction

Illustration accompanying UCL preprint maps 2-micrometre channels that carried tau and amyloid toward the mouse brain surface
Generated illustration

What happened

  • Labelled tau moved through both arteriole walls and channels around venules in roughly similar amounts, consistent with one shared network.
  • In some mouse experiments, tracer reached channels at the brain's upper surface within 7.5 minutes of being given.
  • Mice modelling aspects of Alzheimer's disease had their own amyloid beta inside the channels, as well as the protein the researchers supplied.
  • Labelled tau and amyloid beta applied to living tissue from five brain tumour operations gathered in channels of similar size to those in mice.
  • The team suggests fibroblastic reticular cells form the channels; related cells build the fluid-carrying networks inside lymph nodes.

Compiled by The ScientistSomething wrong?How this is made

Why it matters

  • capability Researchers studying amyloid and tau clearance get a specific structure they can label and image along both previously proposed exit routes.
  • constraint Because the human evidence is tissue kept alive outside the body, any claim about clearance or Alzheimer's risk in people has to wait for work in living patients.
  • precedent Identifying what pumps fluid through the channels is the next step, and it would let researchers test whether slowed transport contributes to disease and whether changing the flow helps.

"The pathways by which toxic proteins are removed from the brain are poorly understood," David Attwell, a neuroscientist on the UCL team, told ScienceAlert [13]. In Alzheimer's disease, amyloid beta and abnormal tau accumulate, so explaining why they build up means studying how they are removed as well as how they are made [19].

Two exits had already been proposed. One runs along the walls of arterioles. The other runs through the spaces around venules and features in explanations of the glymphatic system [16]. The UCL group reports a physical conduit in both places. "We have now shown that, in both these locations, proteins are in fact removed through tiny tubes that appear to be similar to the tubes present in lymph nodes outside the brain (e.g. in the armpit or neck)," Attwell said [14]. The tubes are about 2 micrometres across. They link into a mesh that runs along blood vessels into the membranes covering the brain, and along nerves leaving it [4].

The design choice I like best is the check against artefact. A tracer goes where the experimenter puts it. The amyloid found in the Alzheimer's-model mice was different, because the animals made it themselves [8]. Even so, that finding does not establish how much protein ultimately leaves through the network [8]. Other routes operate alongside it. Some proteins are broken down inside brain tissue, and some cross blood-vessel cells into the bloodstream [17].

The 7.5-minute figure is an arrival time [6]. The thing it doesn't tell you is how much fluid moves, or what moves it. How proteins enter the channels, and how fluid moves along them that fast, is still an open question for the researchers. The beating of blood vessels may play a part, but what drives the flow has not been identified [12].

The human sample is small, with tissue from five tumour operations [9]. It shows that channels resembling the mouse ones are present in human brain tissue and take up these proteins once the tissue is outside the body [10]. Tissue kept outside the body cannot show the whole clearance process in a living person [11]. Attwell drew the same line. "In the future it will be important to demonstrate that these tubes function in the same way in living humans," he said [15].

I think the mouse anatomy is the solid part of this work. The human result shows the structure exists in people but not that it clears anything from a living brain. The study is a preprint and has not been peer reviewed [3].

What to watch

  • Peer-reviewed publication of the UCL preprint, and whether reviewers accept that fibroblastic reticular cells build the channels.
  • Imaging in living humans that shows tracer moving through these tubes, the test Attwell said is needed.
  • Work that identifies what drives flow through the channels and measures what share of brain amyloid and tau leaves by this route.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories